CAMTEK LTD CAMT
Nasdaq · XNAS · stock · Optical Instruments & Lenses
Chart by TradingView
5/9
Piotroski F — financial health
6.8
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $496.1M | $50.7M | $250.3M | $127.5M | $617.0M |
| 2024 | $429.2M | $118.5M | $210.0M | $112.1M | $549.2M |
| 2023 | $315.4M | $78.6M | $147.6M | $71.2M | $476.1M |
| 2022 | $320.9M | $79.9M | $159.9M | $49.6M | $384.1M |
| 2021 | $269.7M | $60.3M | $137.3M | $56.9M | $293.6M |
| 2020 | $155.9M | $21.8M | $73.2M | $23.3M | $227.3M |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 6.8 (safe)
- Working capital / assets 0.627
- Retained earnings / assets 0.307
- EBIT / assets 0.102
- Equity / liabilities 0.96
Source: SEC EDGAR filings · CIK 0001109138 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.